Pharmaceutical

AIFA’s horizon scanning 2024 predictions suggest an influx of ATMPs

In May 2024, Italy’s medicines agency AIFA published a strategic overview, detailing all new active substances that are potentially advancing towards EU marketing authorisation.

May 31, 2024 - 04:00
AIFA’s horizon scanning 2024 predictions suggest an influx of ATMPs
In May 2024, Italy’s medicines agency AIFA published a strategic overview, detailing all new active substances that are potentially advancing towards EU marketing authorisation.
Read the original article

Tags:

Previous Article

BIOSECURE “grandfather” amendment softens impact of US-China trade ban

Next Article

EC grants orphan medicinal product status to Rocket’s RP-A601

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Pharma casts a wide net to hook opportunities in metabolic disorders

Pharma casts a wide net to hook opportunities in metabo...

Aug 7, 2024

STAT+: Pharmalittle: Lilly’s Mounjaro helped people lose 15.7% of body weight; Sanofi earnings boosted by Dupixent

STAT+: Pharmalittle: Lilly’s Mounjaro helped people los...

Apr 27, 2023

STAT+: Global controversy heats up the race to build human embryo models from stem cells

STAT+: Global controversy heats up the race to build hu...

Jun 28, 2023